MedPath

3/7 Resistance Training Method in Cardiac Rehabilitation

Not Applicable
Completed
Conditions
Heart Failure
Coronary Artery Disease
Interventions
Other: 3/7 Resistance Training Method
Other: 3X9 Resistance Training Method
Registration Number
NCT05696990
Lead Sponsor
Université Libre de Bruxelles
Brief Summary

Aim of the clinical monocentric study is to assess the resistance training exercise intervention in patients with Heart Failure with reduced Ejection Fraction (HFrEF) and coronary artery disease that will best improve peak oxygen uptake (Peak Vo2) and leg strength (assessed Isokinetic). The investigators hypothesize that resistance training exercise with induced a high stress metabolic is more important exercise with induced than a lower stress metabolic.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
112
Inclusion Criteria
  • Clinical Coronary artery diseases
  • Heart failure with reduced ejection fraction
Exclusion Criteria
  • angina
  • acutely decompensated heart failure
  • electrocardiographic evidence of ischemia
  • significant valvular disease
  • orthopedic/neurologic disorders that limited exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
3/7 RT method3/7 Resistance Training Methodperform interval- type endurance exercise at high intensity and resistance training with the 3/7 method
3X9 RT method3X9 Resistance Training Methodperform interval- type endurance exercise at high intensity and resistance training with the 3X9 method
Primary Outcome Measures
NameTimeMethod
Change in Peak VO2 after 3 monthsBaseline and 3 months

Change in Peak oxygen consumption (VO2) after three 3 months intervention

Change in strength knee extensor after 3 monthsBaseline and 3 months

Change in strength knee extensor (60°/sec) after three months intervention

Secondary Outcome Measures
NameTimeMethod
Change in Body fat after 3 monthsBaseline and 3 months

Change in Body fat at baseline and 3 months intervention

Change in leg lean mass after 3 monthsBaseline and 3 months

Change in leg lean mass at baseline and 3 months intervention

Change in submaximal exercise capacity after 3 monthsBaseline and 3 months

Submaximal exercise capacity will be measured using watts at the first ventilatory threshold (VT1)

Change in bone mass after 3 monthsBaseline and 3 months

Change in bone mass at baseline and 3 months intervention

Change in 120°/sec strength knee extensor after 3 monthsBaseline and 3 months

Change in strength knee extensor (120°/sec) at baseline and 3 months intervention

Change in lean mass after 3 monthsBaseline and 3 months

Change in lean mass at baseline and 3 months intervention

Change in VE/VCO2 slope after 3 monthsBaseline and 3 months

Change in ventilatory efficiency (VE/VCO2) slope at baseline and 3 months intervention

Change in workload maximal after 3 monthsBaseline and 3 months

Change in workload max at baseline and 3 months intervention

Change in hand grip force after 3 monthsBaseline and 3 months

Change in hand grip force on non dominant hand at baseline and 3 months intervention

Change in resting heart rate variability at rest after 3 monthsBaseline and 3 months

Change in resting heart rate variability at baseline and 3 months intervention

Change 30 s sit-to-stand after 3 monthsBaseline and 3 months

Change 30 s sit-to-stand at baseline and 3 months intervention

Change in Visceral adipose tissue after 3 monthsBaseline and 3 months

Change in Visceral adipose tissue measure by Dual-energy X- ray absorptiometry (DEXA) at baseline and 3 months intervention

Change in isometric strength knee extensor after 3 monthsBaseline and 3 months

Change in strength knee extensor (isometric) at baseline and 3 months intervention

Change in ventilation metaboreflex function after 3 monthsBaseline and 3 months

Change in ventilation during metaboreflex test at baseline and 3 months intervention (Briefly, the subject is asked to exercise with the non-dominant arm by performing two 5 min handgrip manoeu- vres reaching approximately 50% of pre-determined maximal con- traction, in random order, separated by a 30 min interval: one bout with circulatory occlusion during the last 10 s of exercise and the all 3 min recovery phase ('clamp session'). During the clamp session, forearm cuff inflation to 30 mmHg above systolic blood pressure from the last 10 s of exercise till the end of the 3 min recovery phase; after cuff inflation, the subject is instructed to relax. Ergore- ceptor sensitivity is quantified as the percentage of the ventilatory and haemodynamic response to exercise maintained by circulatory occlusion during the third minute compared with the third minute of basal recovery.)

Change in diastolic blood pressure metaboreflex function after 3 monthsBaseline and 3 months

Change in diastolic blood pressure during metaboreflex test at baseline and 3 months intervention

Change in heart rate at rest after 3 monthsBaseline and 3 months

Change in heart rate at baseline and 3 months intervention

Change in 180°/sec strength knee extensor after 3 monthsBaseline and 3 months

Change in strength knee extensor (180°/sec) at baseline and 3 months intervention

Change strength knee extensor in leg extension after 3 monthsBaseline and 3 months

Change in one repetition maximal in leg extensor machine at baseline and 3 months intervention

Change in sub maximal strength knee extensor in leg extension after 3 monthsBaseline and 3 months

Change in 10 repetitions maximal in leg extensor machine at baseline and 3 months intervention

Change in heart rate recovery after 3 monthsBaseline and 3 months

Change in heart rate recovery at baseline and 3 months intervention

Trial Locations

Locations (1)

Erasme Hospital

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath